Updated results from a phase III trial of nivolumab (NIVO) combined with ipilimumab (IPI) in treatment-naive patients (pts) with advanced melanoma (MEL) (CheckMate 067).

Author:

Wolchok Jedd D.1,Chiarion-Sileni Vanna2,Gonzalez Rene3,Rutkowski Piotr4,Grob Jean Jacques5,Cowey C. Lance6,Lao Christopher7,Schadendorf Dirk8,Ferrucci Pier Francesco9,Smylie Michael10,Dummer Reinhard11,Hill Andrew12,Haanen John B. A. G.13,Maio Michele14,McArthur Grant A.15,Walker Dana16,Jiang Joel16,Horak Christine E.16,Larkin James M. G.17,Hodi F. Stephen18

Affiliation:

1. Memorial Sloan Kettering Cancer Center, New York, NY;

2. Oncology Institute of Veneto IRCCS, Padua, Italy;

3. University of Colorado Cancer Center, Denver, CO;

4. Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland;

5. Hospital de la Timone, Marseille, France;

6. Texas Oncology/Baylor Sammons Cancer Center/US Oncology, Dallas, TX;

7. University of Michigan, Ann Arbor, MI;

8. Department of Dermatology, University of Essen, Essen, Germany;

9. European Institute of Oncology, Milan, Italy;

10. Cross Cancer Institute, Edmonton, AB, Canada;

11. Universitats Spital, Zurich, Switzerland;

12. Tasman Oncology Research, Queensland, Australia;

13. Netherlands Cancer Institute, Amsterdam, Netherlands;

14. Medical Oncology and Immunotherapy University Hospital of Siena, Siena, Italy;

15. Peter MacCallum Cancer Centre, East Melbourne, Australia;

16. Bristol-Myers Squibb, Princeton, NJ;

17. The Royal Marsden Hospital, London, United Kingdom;

18. Dana-Farber Cancer Institute, Boston, MA;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3